Recurrent Acute Biphenotypic Leukemia Active Not Recruiting Phase 2 Trials for Venetoclax (DB11581)

Back to Recurrent Acute Biphenotypic Leukemia

Also known as: Acute, recurrent Biphenotypic Leukemia

IndicationStatusPhase
DBCOND0106027 (Recurrent Acute Biphenotypic Leukemia)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04975919
Venetoclax in Combination with Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaTreatment
NCT03404193
Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic SyndromeTreatment